Open AccessEffect of new persistent opioid use on physiologic and psychologic outcomes following bariatric surgery
Author(s) -
Margaret E. Smith,
Jay S. Lee,
Aaron J. Bonham,
Oliver A. Varban,
Jonathan F. Finks,
Arthur M. Carlin,
Amir A. Ghaferi
Publication year - 2018
Publication title -
surgical endoscopy/surgical endoscopy and other interventional techniques
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.457
H-Index - 152
eISSN - 1432-2218
pISSN - 0930-2794
DOI - 10.1007/s00464-018-6542-0
Subject(s) - medicine , opioid , depression (economics) , abdominal surgery , surgery , body mass index , sleeve gastrectomy , complication , weight loss , obesity , gastric bypass , receptor , economics , macroeconomics
New persistent opioid use following surgery is a common iatrogenic complication, developing in roughly 6% of patients after elective surgery. Despite increased awareness of misuse and associated morbidity, opioids remain the cornerstone of pain management in bariatric surgery. The potential impact of new persistent opioid use on long-term postoperative outcomes is unknown. We sought to determine the relationship between new persistent opioid use and 1-year postoperative outcomes for patients undergoing bariatric surgery.